StockData
10x Genomics, Inc. logo

10x Genomics, Inc. (TXG) stock

TXGNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 9/30106% above fair value
$56.30+1.31 (+2.38%)

Close on Nov 17, 2026Market cap $7.34BP/E –Yield –

10x Genomics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

10x Genomics's total debt was $0 at Dec 31, 2020. For fiscal 2020 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$0-100.0%
FY2019Dec 31, 2019$29.72M+0.1%
FY2018Dec 31, 2018$29.68M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2020Dec 31, 2020$0-100.0%
Q3 FY2020Sep 30, 2020$0-100.0%
Q2 FY2020Jun 30, 2020$0-100.0%
Q1 FY2020Mar 31, 2020$0–
Q4 FY2019Dec 31, 2019$29.72M–
Q3 FY2019Sep 30, 2019$29.69M–
Q4 FY2018Dec 31, 2018$29.68M–

More 10x Genomics figures

See a number that looks wrong?